Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Morad Askari

Surgery of the Hand Coral Gables, FL Medical Doctor

NPI 1174715551 CMS profile 98793

2903 Salzedo St, Coral Gables, FL 33134

Open in the dashboard

General payments

$36,249

249 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Morad Askari of Coral Gables, FL is reported in the CMS Open Payments database as having received $36,249 across 249 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,629 31
2024 General $1,731 29
2023 General $8,806 39
2022 General $5,307 34
2021 General $1,796 28
2020 General $4,688 40
2019 General $11,292 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Morad Askari
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Morad Askari were reported at $2,629. Among 212 Surgery of the Hand profiles paid that year, the median was $312 and the middle half received between $111 and $999.

Show as a table
Year Morad Askari Surgery of the Hand median Middle half National median
2019 $11,292 $337 $119–$1,310 $163
2020 $4,688 $149 $52–$588 $114
2021 $1,796 $251 $78–$776 $132
2022 $5,307 $260 $116–$1,251 $149
2023 $8,806 $288 $113–$961 $160
2024 $1,731 $372 $125–$888 $164
2025 $2,629 $312 $111–$999 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $9,071 7 payments
  2. Arthrex, Inc. $5,478 22 payments
  3. Integra LifeSciences Corporation $5,128 39 payments
  4. KCI USA, Inc $2,812 7 payments
  5. Allergan Inc. $2,666 19 payments
  6. AbbVie, Inc. $1,849 20 payments
  7. Musculoskeletal Transplant Foundation Inc. $1,431 6 payments
  8. TELA Bio, Inc. $1,376 23 payments
  9. Smith+Nephew, Inc. $1,206 32 payments
  10. Mentor Worldwide LLC $1,026 11 payments
  11. Other $4,207 63 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,828 226 payments
  2. Consulting Fee $5,400 4 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $5,000 1 payment
  4. Education $3,809 4 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,250 3 payments
  6. Travel and Lodging $2,865 10 payments
  7. Entertainment $97 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose Wound Care $8,873 6 payments
  2. Kerecis Omega3 GraftGuide $8,789 5 payments
  3. Kerecis Omega3 SurgiClose Wound Care $5,051 2 payments
  4. Kerecis Omega3 SurgiClose Wound Care $5,051 2 payments
  5. Kerecis Omega3 Marigen Wound Care $5,051 2 payments
  6. Kerecis Omega3 Marigen Wound Care $3,822 4 payments
  7. Kerecis Omega3 Marigen Wound Care $3,738 3 payments
  8. Kerecis Omega3 Marigen Wound Care $3,738 3 payments
  9. ALLODERM $2,512 16 payments
  10. PANTA NAIL $2,250 2 payments
  11. Other $33,724 349 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$77

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

100%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 12 $77

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$44,871

Medicare's payments for the services billed

Medicare patients

55

Average age 74

Services billed

498

24 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Ischemic heart disease 49%
Depression 47%
Heart failure 38%
Chronic kidney disease 38%
Diabetes 36%
Atrial fibrillation 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $19
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

249 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record